EPHX2 and Stroke: In the current study, sEH inhibitor was administered before stroke, which has limited value as a stroke therapy, but is ideal for determining the role of sEH in the exacerbation of stroke injury in brains of type 2 diabetic mice, which was the goal of the current study.